Publikacje


Liczba publikacji: 140
sortuj wg: rok publikacji | nazwa czasopisma | data modyfikacji w bazie

Results of an international comparison for the activity measurement of 177Lu.


B.E. Zimmerman, ... , T. Dziel, ... et al.
Appl. Radiat. Isot. Vol. 70 (2012) 1825-1830

Standardization of the 85Sr solution by three methods


R. Broda, T. Dziel, A. Muklanowicz
Appl. Radiat. Isot. Vol. 70 (2012) 2222-2226

Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients


M. Opalinska, ... , R. Mikołajczak, P. Garnuszek, M. Maurin, U. Karczmarczyk, ... et al.
Eur. J. Nucl. Med. Mol. Imaging Vol. 39 (2012) 673-682

Pharmaceutical development on DOTA-anti-CD20 monoclonal antibody for Lu-177 labelling


W. Wojdowska, U. Karczmarczyk, E. Byszewska, P. Garnuszek, R. Mikołajczak
Eur. J. Nucl. Med. Mol. Imaging Vol. SUP2 (2012) S533-S533

Beta-emitting radionuclides for peptide receptor radionuclide therapy


J. Parus, R. Mikołajczak
Curr. Top. Med. Chem. Vol. 12 (2012)

Clinical indications to the use of 99mTc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors


M.G. Parisella, ... , R. Mikołajczak, ... et al.
Q J Nucl Med Mol Imaging Vol. 56 (2012) 90-98

44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET?


E. Koumarianou, ... , D. Pawlak, R. Mikołajczak, ... et al.
Appl. Radiat. Isot. Vol. 70 (2012) 2669-2676

Recombinant fragment of an antibody tailored for direct radioiodination


J. Sedláček, ... , R. Mikołajczak, ... et al.
J Labelled Comp Radiopharm Vol. 55 (2012) 52 - 56

Nanodosimetry of Auger Electrons - experiment and modelling


S. Pszona, A. Bancer, B. Grosswendt, W. Czarnacki, I. Cieszykowska
Radiat. Meas. Vol. 47 (2012) 1092-1096

Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states


P. Garnuszek, D. Pawlak, M. Maurin, D. Jankovic, U. Karczmarczyk, R. Mikołajczak
Nucl Med Rev Vol. 15 (2012) 95-100

Search of radiation hormesis in plants: irradiation of the cress (Lepidium sativum L.)


K.W. Fornalski, Ł. Adamowski, T.W. Turowski, J. Wojnarowicz
Nukleonika Vol. 57 (2012) 421

Radiopharmaceuticals in Cardiology


R. Mikołajczak, P. Garnuszek
Nucl Med Rev Vol. 15 (2012) 39-45

Repeated cycles of peptide receptor radionuclide therapy (PRRT) - Results and side-effects of the radioisotope (90)Y-DOTA TATE, (177)Lu-DOTA TATE or (90)Y/(177)Lu-DOTA TATE therapy in patients with disseminated NET.


D. Pach, ... , R. Mikołajczak, D. Pawlak, ... et al.
Radiother. Oncol. Vol. 102 (2012) 45-50

Ga-68 labelling of of DOTATATE for clinical application in PET/CT of neuroendocrine tumors


D. Pawlak, J. Kunikowska, L. Królicki, W. Wojdowska, L. Grabowska, R. Mikołajczak
J Labelled Comp Radiopharm Vol. 54 (2011) S343-S343

Synthesis and quality control of Ga-68-citrate for PET/CT, preliminary results


D. Pawlak, W. Wojdowska, J. Kunikowska, J. Marchel, L. Królicki, R. Mikołajczak
J Labelled Comp Radiopharm Vol. 54 (2011) S342-S342

Production of 18F by Proton Irradiation of C6H6NF and C6H5NF2


E. Betak, R. Mikołajczak, J. Staniszewska, S. Mikołajewski, E. Rurarz, J. Wojtkowska
Nukleonika Vol. 56 (2011) 269-276

Thermal diffusion of 57Co into rhodium matrix as a second step in preparing Mössbauer sources


I. Cieszykowska, M. Żółtowska, P. Zachariasz, A. Piasecki, T. Janiak, M. Mielcarski
Appl. Radiat. Isot. Vol. 69 (2011) 1193-1197

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)


A. Sowa-Staszczak, ... , R. Mikołajczak, D. Pawlak, ... et al.
Eur. J. Nucl. Med. Mol. Imaging Vol. 38 (2011) 1669-1674

Clinical results of radionuclide therapy of neuroendocrine tumours with (90)Y-DOTATATE and tandem (90)Y/ (177)Lu-DOTATATE: which is a better therapy option?


J. Kunikowska, L. Królicki, A. Hubalewska-Dydejczyk, R. Mikołajczak, A. Sowa-Staszczak, D. Pawlak
Eur. J. Nucl. Med. Mol. Imaging Vol. 38 (2011) 1788-1797

Can treatment using radiolabelled somatostatin analogue increase the survival rate in patients with non-functioning neuroendocrine pancreatic tumours?


A. Sowa-Staszczak, ... , R. Mikołajczak, D. Pawlak, ... et al.
Nucl Med Rev Vol. 14 (2011) 73-78

Comparison of receptor affinity of natSc-DOTA-TATE versus natGa-DOTA-TATE


E. Koumarianou, D. Pawlak, A. Korsak, R. Mikołajczak
Nucl Med Rev Vol. 14 (2011) 85-89

Efficacy and safety of (90)Y-DOTATATE therapy in neuroendocrine tumours


A. Sowa-Staszczak, ... , R. Mikołajczak, ... et al.
Endokrynologia Polska Vol. 62 (2011) 392-400

Patient-Specific Radiation Dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in Neuroendocrine Tumors  


J. Grimes, ... , R. Mikołajczak, ... et al.
J Nucl Med Vol. 52 (2011) 1474-1481

The penetration of topically applied ointment containing hyaluronic acid in rabbits tissues


B. Birkenfeld, ... , R. Mikołajczak, E. Byszewska-Szpocińska, ... et al.
Polish J Veterinary Sci. Vol. 14 (2011) 621-627

Electrodeposition of carrier-free 57Co on rhodium as an approach to the preparation of Mössbauer sources


I. Cieszykowska, M. Żółtowska, M. Mielcarski
Appl. Radiat. Isot. Vol. 69 (2011) 142-145

Comparison of triple-to-double coincidence ratio (TDCR) efficiency calculations and uncertainty assessments for 99Tc.


B.E. Zimmerman, ... , R. Broda, ... et al.
Appl. Radiat. Isot. Vol. 68 (2010) 1477-1481

Comparison of 99Tcm and 131I in Polish hospitals, 2007


R. Broda, T. Dziel, A. Muklanowicz, A. Listkowska, Ł. Pieńkowski, A. Patocka, E. Kołakowska
Appl. Radiat. Isot. Vol. 68 (2010) 1278-1281

COSTBM0607-WG2, Preparation of therapeutic doses of Lu-177 or Y-90 DOTATATE for PRRT


D. Pawlak, W. Wojdowska, R. Mikołajczak
Nucl. Med. Biol. Vol. 37 (2010) 723-723

Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent


D. Máthé, ... , D. Pawlak, ... et al.
Nucl. Med. Biol. Vol. 37 (2010) 215-226

Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs) a phase II study


J.B. Ćwikła, ... , R. Mikołajczak, D. Pawlak, ... et al.
Ann. Oncolog. Vol. 21 (2010) 787-794

3

Nasza siedziba

Produkty

Certyfikaty

Newsletter

Subskrybuj nasz Newsletter, aby otrzymywac informacje o nowosciach z naszej strony.

Incorrect please try again
kod z obrazka: Enter the numbers you hear: